NP / PA
Cookeville Regional Medical Group, INC
Cookeville Regional Medical Group, INC was paid $1.82M by Medicaid between Jan 2018 and Dec 2024, across 69 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 43% of everything it billed.
33Billing provider infoCOOKEVILLE REGIONAL MEDICAL GROUP, INC
COOKEVILLE, TN 38501
COOKEVILLE, TN 38501
33aNPI1649202102assigned 07/07/2006
33bProvider typeSurgical Physician Assistant
28Total paid$1.82M
24GClaims221,840
24DCodes billed69
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Surgical Physician Assistant providers in Tennessee
Rank by total paid#1 of 15
Median peer was paid$40K
This provider vs. median45×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 15,929 | $322K | |
| 2019 | 18,822 | $358K | |
| 2020 | 13,951 | $256K | |
| 2021 | 50,405 | $338K | |
| 2022 | 60,908 | $252K | |
| 2023 | 41,552 | $151K | |
| 2024incomplete | 20,273 | $143K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 43% | 32,495 | 26,850 | $786K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 14% | 14,447 | 11,957 | $250K |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | 12% | 3,917 | 1,335 | $210K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 8.1% | 2,754 | 2,315 | $147K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 5.5% | 1,628 | 1,276 | $99K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 4.9% | 2,449 | 2,065 | $89K |
| 99232 | Hospital visit by a doctor, follow-up daySubsequent hospital care, per day, moderate complexity | 1.9% | 2,969 | 1,139 | $34K |
| 99233 | Hospital visit by a doctor, follow-up day (complex)Prolong inpt eval add15 m | 1.5% | 1,595 | 688 | $28K |
| 94729 | 1.4% | 2,119 | 1,791 | $26K | |
| 94727 | 1.1% | 2,012 | 1,700 | $20K | |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | <1% | 563 | 468 | $13K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 1,118 | 555 | $11K |
57 more codes
| 94010 | <1% | 1,566 | $11K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 4,099 | $8K |
| 82962 | <1% | 6,473 | $7K | |
| 94060 | <1% | 448 | $7K | |
| 99292 | <1% | 104 | $6K | |
| 51798 | <1% | 1,727 | $6K | |
| 51701 | <1% | 324 | $6K | |
| 81001 | <1% | 5,871 | $5K | |
| 99443 | <1% | 410 | $5K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,107 | $5K |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | <1% | 107 | $5K |
| 36415 | Collection of venous blood by venipuncture | <1% | 4,962 | $4K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 457 | $4K |
| 95251 | <1% | 323 | $3K | |
| 90686 | <1% | 323 | $3K | |
| 3078F | <1% | 13,023 | $2K | |
| 3074F | <1% | 12,355 | $2K | |
| 99222 | Initial hospital care, per day, moderate complexity | <1% | 29 | $2K |
| 99406 | <1% | 707 | $2K | |
| 74018 | <1% | 154 | $2K | |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | <1% | 31 | $2K |
| 99442 | <1% | 139 | $2K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 54 | $1K |
| 95811 | <1% | 13 | $951.69 | |
| 99223 | Prolong inpt eval add15 m | <1% | 32 | $734.98 |
| 99205 | Prolong outpt/office vis | <1% | 12 | $566.04 |
| 1160F | <1% | 25,728 | $550.80 | |
| 99308 | Subsequent nursing facility care, per day, straightforward | <1% | 51 | $536.18 |
| 3008F | <1% | 27,069 | $510.79 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 50 | $459.90 |
| 3079F | <1% | 1,570 | $406.82 | |
| 90962 | <1% | 17 | $393.11 | |
| 3075F | <1% | 630 | $381.25 | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 27 | $342.96 |
| 94618 | <1% | 43 | $260.69 | |
| J1071 | Injection, testosterone cypionate, 1 mg | <1% | 82 | $208.68 |
| 90961 | <1% | 14 | $189.31 | |
| 90960 | End-stage renal disease related services monthly, for patients 20 years and older, with 4 or more face-to-face visits | <1% | 30 | $179.10 |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | <1% | 75 | $178.58 |
| 3077F | <1% | 454 | $170.00 | |
| 99309 | Subsequent nursing facility care, per day, low to moderate complexity | <1% | 28 | $167.21 |
| G0008 | Administration of influenza virus vaccine | <1% | 352 | $130.96 |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 17 | $78.15 |
| 81002 | <1% | 69 | $71.92 | |
| J1040 | Injection, methylprednisolone acetate, 80 mg | <1% | 17 | $62.62 |
| 81005 | <1% | 78 | $55.11 | |
| 90662 | <1% | 64 | $53.37 | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 13 | $34.98 |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 334 | $24.57 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 42 | $19.07 |
| 1159F | <1% | 21,311 | $0.07 | |
| 1036F | <1% | 17,025 | $0.06 | |
| 1034F | <1% | 2,424 | $0.01 | |
| 1126F | 0% | 685 | $0.00 | |
| 1125F | 0% | 460 | $0.00 | |
| 3080F | 0% | 81 | $0.00 | |
| 1035F | 0% | 84 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialKEY, MARILYN (CEO)
| Provider | Location | Paid |
|---|---|---|
| Cookeville Regional Medical Center | Cookeville, TN | $17.12M |
| Cookeville Regional Medical Center | Cookeville, TN | $1.13M |
| CRMC Mso Sub 1, Incorporated | Cookeville, TN | $651K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.